Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bofill

Showing results (581-590 of 594) with videos related to

Pageof 60
Sort By:
Nature Communications|July 11, 2024
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early responseFara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, et al.
Scientific Reports|October 6, 2022
The Catalan Surveillance Network of SARS-CoV-2 in Sewage: design, implementation, and performanceLaura Guerrero-Latorre, Neus Collado, Nerea Abasolo, et al.
Breast (Edinburgh, Scotland)|October 7, 2022
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trialJavier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, et al.
Frontiers in Oncology|March 12, 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern SpainAlejandro Falcón-González, Elisenda Llabrés-Valenti, Fernando Henao-Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)Ana Lluch, Carlos H Barrios, Laura Torrecillas, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinomaLorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, et al.
Fertility and Sterility|December 4, 2020
Top 10 priorities for future infertility research: an international consensus development studyJ M N Duffy, G D Adamson, E Benson, et al.
Nature|April 24, 2025
Punic people were genetically diverse with almost no Levantine ancestorsHarald Ringbauer, Ayelet Salman-Minkov, Dalit Regev, et al.
The Science of the Total Environment|November 25, 2021
Minimizing errors in RT-PCR detection and quantification of SARS-CoV-2 RNA for wastewater surveillanceWarish Ahmed, Stuart L Simpson, Paul M Bertsch, et al.
Anaesthesia, Critical Care & Pain Medicine|May 24, 2025
Outcomes and predictors of mortality in patients with severe COVID-19 and COPD admitted to ICU: A multicenter studyLaia Fernández-Barat, Ana Motos, Joan Canseco-Ribas, et al.
Pageof 60

Showing results (581-590 of 594) with videos related to

Sort By:
Pageof 60
Nature Communications|July 11, 2024
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early responseFara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, et al.
Scientific Reports|October 6, 2022
The Catalan Surveillance Network of SARS-CoV-2 in Sewage: design, implementation, and performanceLaura Guerrero-Latorre, Neus Collado, Nerea Abasolo, et al.
Breast (Edinburgh, Scotland)|October 7, 2022
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2- advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trialJavier Salvador Bofill, Fernando Moreno Anton, Cesar Augusto Rodriguez Sanchez, et al.
Frontiers in Oncology|March 12, 2026
Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern SpainAlejandro Falcón-González, Elisenda Llabrés-Valenti, Fernando Henao-Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)Ana Lluch, Carlos H Barrios, Laura Torrecillas, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2024
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinomaLorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, et al.
Fertility and Sterility|December 4, 2020
Top 10 priorities for future infertility research: an international consensus development studyJ M N Duffy, G D Adamson, E Benson, et al.
Nature|April 24, 2025
Punic people were genetically diverse with almost no Levantine ancestorsHarald Ringbauer, Ayelet Salman-Minkov, Dalit Regev, et al.
The Science of the Total Environment|November 25, 2021
Minimizing errors in RT-PCR detection and quantification of SARS-CoV-2 RNA for wastewater surveillanceWarish Ahmed, Stuart L Simpson, Paul M Bertsch, et al.
Anaesthesia, Critical Care & Pain Medicine|May 24, 2025
Outcomes and predictors of mortality in patients with severe COVID-19 and COPD admitted to ICU: A multicenter studyLaia Fernández-Barat, Ana Motos, Joan Canseco-Ribas, et al.
Pageof 60